Ident. | Authors (with country if any) | Title |
---|
000152 (2014) |
Massimo Pandolfo [Belgique] ; Javier Arpa [Espagne] ; Martin B. Delatycki [Australie] ; Kim Hanh Le Quan Sang [France] ; Caterina Mariotti [Italie] ; Arnold Munnich [France] ; Irene Sanz-Gallego [Espagne] ; Geneieve Tai [Australie] ; Mark A. Tarnopolsky [Canada] ; Franco Taroni [Italie] ; Michael Spino [Canada] ; Fernando Tricta [Canada] | Deferiprone in Friedreich ataxia: A 6‐Month randomized controlled trial |
000153 (2014) |
D. M. Rubel [Australie] ; L. Spelman [Australie] ; D. F. Murrell [Australie] ; J. See [Australie] ; D. Hewitt [Australie] ; P. Foley [Australie] ; C. Bosc [France] ; D. Kerob [France] ; N. Kerrouche [France] ; H. C. Wulf [Danemark] ; S. Shumack [Australie] | Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial |
000256 (2013) |
C. Roux [France] ; A. Fahrleitner-Pammer [Autriche] ; P. R. Ho [États-Unis] ; F. Hawkins [Espagne] ; L. C. Hofbauer [Allemagne] ; M. Micaelo [Portugal] ; S. Minisola [Italie] ; N. Papaioannou [Grèce] ; M. Stone [Royaume-Uni] ; J. Wark [Australie] ; M. C. Zillikens [Pays-Bas] ; I. Ferreira [États-Unis] ; S. Siddhanti [États-Unis] ; R. B. Wagman [États-Unis] ; J. P. Brown [Canada] | THU0418 Denosumab Versus Risedronate: Efficacy and Safety in Postmenopausal Women Suboptimally Adherent to Alendronate Therapy in a Randomized Open-Label Study |
000277 (2013) |
G. R. Burmester [Allemagne] ; A. Rubbert-Roth [Allemagne] ; A. Cantagrel [France] ; S. Hall [Australie] ; P. Leszczynski [Pologne] ; D. Feldman [Brésil] ; M. J. Rangaraj ; G. Roane ; C. Ludivico [États-Unis] ; E. Mysler [Argentine] ; L. Rowell [Royaume-Uni] ; I. Vranic [Royaume-Uni] | SAT0105 Summacta: A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy Of Tocilizumab SC Versus Tocilizumab IV, in Combination with Traditional Dmards in Patients With Moderate to Severe Ra |
000431 (2013) |
C. Cooper [Royaume-Uni] ; R. Chapurlat [France] ; C. Christiansen [Danemark] ; H. Genant [États-Unis] ; N. Bellamy [Australie] ; W. Bensen [Canada] ; F. Navarro [Espagne] ; J. Badurski [Pologne] ; E. Nasonov [Russie] ; X. Chevalier [France] ; P. Sambrook [Australie] ; T. Spector [Royaume-Uni] ; J.-Y. Reginster [Belgique] | AB0962 Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: A randomized, double-blind, placebo-controlled international trial |
000437 (2013) |
Bernard Chevalier [France] ; Carlo Dimario [Royaume-Uni] ; Franz-Josef Neumann [Allemagne] ; Donald E. Cutlip [États-Unis] ; David O. Williams [États-Unis] ; John Ormiston [Nouvelle-Zélande] ; Eberhard Grube [Allemagne] ; Robert Whitbourn [Australie] ; Jessie Coe [États-Unis] ; Lewis B. Schwartz [États-Unis] | A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus‐ vs. Paclitaxel‐eluting stents in de novo occlusive lesions in coronary arteries: Five‐year results from the ZOMAXX I trial |
000533 (2012) |
Bertram Pitt [États-Unis] ; Gerasimos Filippatos [Grèce] ; Mihai Gheorghiade [États-Unis] ; Lars Kober [Danemark] ; Henry Krum [Australie] ; Piotr Ponikowski [Pologne] ; Christina Nowack [Allemagne] ; Peter Kolkhof [Allemagne] ; So-Young Kim [Allemagne] ; Faiez Zannad [France] | Rationale and design of ARTS: a randomized, double‐blind study of BAY 94‐8862 in patients with chronic heart failure and mild or moderate chronic kidney disease |
000892 (2011) |
B. Dréno [France] ; R. Kaufmann [Allemagne] ; S. Talarico [Brésil] ; V. Torres Lozada [Mexique] ; M. A. Rodríguez-Castellanos [Mexique] ; M. G Mez-Flores [Mexique] ; J. De Maubeuge [Belgique] ; M. Berg [Suède] ; P. Foley [Australie] ; A. Sysa-Jedrzejowska [Pologne] ; N. Kerrouche [France] ; F. Paliargues [France] ; V. Bettoli [Italie] | Combination therapy with adapalene–benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double‐blind controlled study |
000C21 (2010) |
S. Czernichow [Australie, France] ; C. M. Y. Lee [Australie] ; F. Barzi [Australie] ; J. R. Greenfield [Australie] ; L. A. Baur [Australie] ; J. Chalmers [Australie] ; M. Woodward [Australie] ; R. R. Huxley [Australie] | Efficacy of weight loss drugs on obesity and cardiovascular risk factors in obese adolescents: a meta‐analysis of randomized controlled trials |
000E52 (2009) |
Annamaria Colao ; Paolo Cappabianca [Italie] ; Philippe Caron [France] ; Ernesto De Menis [Italie] ; Andrew J. Farrall [Royaume-Uni] ; Monica R. Gadelha [Brésil] ; Abdel Hmissi [Suisse] ; Aled Rees [Royaume-Uni] ; Martin Reincke [Allemagne] ; Mitra Safari [Suisse] ; Guy T'Sjoen [Belgique] ; Hakim Bouterfa [Suisse] ; Ross C. Cuneo [Australie] | Octreotide LAR vs. surgery in newly diagnosed patients with acromegaly: a randomized, open‐label, multicentre study |
000F80 (2009) |
N. Venketasubramanian [Singapour] ; C. L. H. Chen [Singapour] ; R. N. Gan [Singapour] ; B. P. L. Chan [Singapour] ; H. M. Chang [Singapour] ; S. B. Tan [Singapour] ; D. Picard [Singapour] ; J. C. Navarro [Philippines] ; A. C. Baroque Ii [Philippines] ; N. Poungvarin [Thaïlande] ; G. A. Donnan [Australie] ; M. G. Bousser [France] | A double‐blind, placebo‐controlled, randomized, multicenter study to investigate CHInese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES Study) |
001142 (2008) |
R. Kaufmann [Allemagne] ; L. Spelman [Australie] ; W. Weightman [Australie] ; J. Reifenberger [Allemagne] ; R. Szeimies [Allemagne] ; E. Verhaeghe [Belgique] ; N. Kerrouche [France] ; V. Sorba [France] ; H. Villemagne [France] ; L. E. Rhodes [Royaume-Uni] | Multicentre intraindividual randomized trial of topical methyl aminolaevulinate–photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities |
001466 (2007) |
D. F. Murrell [Australie] ; S. Calvieri [Italie] ; J. P. Ortonne [France] ; V. C. Ho [Canada] ; S. Weise-Riccardi [Suisse] ; N. Barbier [Suisse] ; C. F. Paul [France] | A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids |
001689 (2006) |
L. Dubertret ; W. Sterry ; J. D. Bos ; S. Chimenti ; S. Shumack ; C. G. Larsen ; N. H. Shear ; K. A. Papp | CLinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate‐to‐severe plaque psoriasis: results from a phase III international randomized, placebo‐controlled trial |
001803 (2005) |
Marcus D. Flather [Royaume-Uni] ; Marcelo C. Shibata [Royaume-Uni, Canada] ; Andrew J. S. Coats [Australie] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Aleksandr Parkhomenko [Ukraine] ; Joszef Borbola [Hongrie] ; Alain Cohen-Solal [France] ; Dan Dumitrascu [Roumanie] ; Roberto Ferrari [Italie] ; Philippe Lechat [France] ; Jordi Soler-Soler [Espagne] ; Luigi Tavazzi [Italie] ; Lenka Spinarova [République tchèque] ; Jiri Toman [République tchèque] ; Michael Bo Hm [Allemagne] ; Stefan D. Anker [Allemagne] ; Simon G. Thompson [Royaume-Uni] ; Philip A. Poole-Wilson [Royaume-Uni] | Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) |
001813 (2005) |
A. B. Gottlieb [Suisse] ; C. E. M. Griffiths [Suisse] ; V. C. Ho [Suisse] ; M. Lahfa [Suisse] ; U. Mrowietz [Suisse] ; D. F. Murrell [Suisse] ; J-P. Ortonne [Suisse] ; G. Todd [Suisse] ; R. Cherill [Suisse] ; I. Marks [Suisse] ; S. Emady-Azar [Suisse] ; C. F. Paul [Suisse] | Oral pimecrolimus in the treatment of moderate to severe chronic plaque‐type psoriasis: a double‐blind, multicentre, randomized, dose‐finding trial |
001860 (2005) |
Howard Feldman [Canada] ; Serge Gauthier [Canada] ; Jane Hecker [Australie] ; Bruno Vellas [France] ; Yikang Xu [États-Unis] ; John R. Ieni [États-Unis] ; Elias M. Schwam [États-Unis] | Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo‐controlled trial |
001F95 (2000) |
P. Corris [France] ; A. Glanville [France] ; K. Mcneil [France] ; T. Wahlers [France] ; R. Mamelok [France] ; C. Knoop [France] ; J. Egan [France] ; R. Speich [France] ; G. Martensson [France] ; U. Svendsen [France] ; M. Hummel [France] ; J. Borro [France] ; M. C. Carreno [France] ; P. Morales [France] ; A. Varela [France] ; C. Bravo [France] ; C. Chan [France] ; R. Lama [France] ; A. Roman [France] ; A. Salvatierra [France] ; O. Van Der Bij [France] ; G. Verleden [France] ; S. Bell [France] ; L. Caubarrere [France] ; M. Stern [France] ; L. Eriksson [France] ; O. Geiran [France] ; R. Guillemain [France] | One year analysis of an ongoing international randomized study of mycophenolate mofetil (MMF) vs azathioprine (AZA) in lung transplantation |
002062 (2000) |
Robert A. De Man ; Patrick Marcellin ; Flavio Habal ; Paul Desmond ; Teresa Wright ; Toby Rose ; Regina Jurewicz ; Clarence Young | A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen–positive hepatitis B |
002343 (1998) |
Frans J. M. Debruyne [Pays-Bas] ; Robin Murray [Australie] ; Yves Fradet [Canada] ; Jan E. Johansson [Suède] ; Chris Tyrrell [Royaume-Uni] ; Francesco Boccardo [Italie] ; Louis Denis [Belgique] ; J. Michael Marberger [Autriche] ; Daniel Brune [France] ; Jens Rassweiler [Allemagne] ; Tony Vangeneugden [Belgique] ; Jan Bruynseels [Belgique] ; Monique Janssens [Belgique] ; Peter De Porre [Belgique] | Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate |
002A05 (1993) |
M. Goldminc [France] ; G. Maddern [Australie] ; E. Le Prise [France] ; B. Meunier [France] ; J. P. Campion [France] ; B. Launois [France] | Oesophagectomy by a transhiatal approach or thoracotomy: A prospective randomized trial |